Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts

被引:2
|
作者
Zhao, Chongyu [1 ]
He, Chaobin [1 ]
Lu, Jiawei [2 ]
Huang, Xin [1 ]
Chen, Cheng [3 ]
Lin, Xiaojun [1 ]
机构
[1] Sun Yat sen Univ, Dept Pancreatobiliary Surg, State Key Lab Oncol South China, Collaborat Innovat Centerfor Canc Med Canc Ctr, Guangzhou, Peoples R China
[2] Dalian Med Univ, Dept Oncol, Hosp 2, Dalian, Peoples R China
[3] Dalian MedicalUnivers, Dept Cardiol, Affiliated Hosp 1, Dalian, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
intrahepatic cholangiocarcinoma; post-progression survival; recurrence; prognosis; nomogram; HEPATOCELLULAR-CARCINOMA; MANAGEMENT; RESECTION; DIAGNOSIS; PREDICT;
D O I
10.3389/fonc.2022.832038
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThe post-progression survival (PPS) of recurred intrahepatic cholangiocarcinoma (iCCA) patients relates to the characteristics of tumor progression. Moreover, the prediction model of PPS in those patients has not been well established. This study aimed at developing a novel nomogram for predicting PPS in recurred iCCA patients. MethodClinical characteristics were retrospectively collected in 396 patients diagnosed with iCCA from cohorts of Sun Yat-sen University Cancer Center (SYSUCC) and the First Hospital of Dalian Medical University (FHDMU). The PPS in patients with different progression patterns was investigated. The nomogram of PPS was established with the Cox regression model in the primary cohort. Then the nomogram was verified in the external validation cohort. ResultsLiver progression was the commonest pattern (42.08%) in recurred iCCA patients, while patients with local LN progression had significantly better PPS than those with other patterns. The independent prognostic factors comprised elevated CEA levels, tumor differentiation, N stage 8th, adjuvant therapy, Local LN metastasis, Liver Metastasis only, and Multiple Metastasis. The nomogram constructed on these factors achieved satisfied C-indexes of 0.794 (95% CI 0.769-0.828) and 0.827 (0.779-0.876) for the training and validation cohorts, respectively. These values were significantly higher than those of the 8th TNM stage system (all p < 0.001). The recurred iCCA patients could be precisely classified into high- and low-risk groups according to the cutoff point of this nomogram (p < 0.01). ConclusionThe investigation of progression patterns and the development of this nomogram can offer new evidence to precisely postoperative and post-progression management of iCCA patients.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study
    Pugh, Sian A.
    Bowers, Megan
    Ball, Alexandre
    Falk, Stephen
    Finch-Jones, Meg
    Valle, Juan W.
    O'Reilly, Derek A.
    Siriwardena, Ajith K.
    Hornbuckle, Joanne
    Rees, Myrddin
    Rees, Charlotte
    Iveson, Tim
    Hickish, Tamas
    Maishman, Tom
    Stanton, Louise
    Dixon, Elizabeth
    Corkhill, Andrea
    Radford, Mike
    Garden, O. James
    Cunningham, David
    Maughan, Tim S.
    Bridgewater, John A.
    Primrose, John N.
    BRITISH JOURNAL OF CANCER, 2016, 115 (04) : 420 - 424
  • [2] Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study
    Siân A Pugh
    Megan Bowers
    Alexandre Ball
    Stephen Falk
    Meg Finch-Jones
    Juan W Valle
    Derek A O'Reilly
    Ajith K Siriwardena
    Joanne Hornbuckle
    Myrddin Rees
    Charlotte Rees
    Tim Iveson
    Tamas Hickish
    Tom Maishman
    Louise Stanton
    Elizabeth Dixon
    Andrea Corkhill
    Mike Radford
    O James Garden
    David Cunningham
    Tim S Maughan
    John A Bridgewater
    John N Primrose
    British Journal of Cancer, 2016, 115 : 420 - 424
  • [3] A Prognostic Nomogram for Overall Survival of Patients After Hepatectomy for Intrahepatic Cholangiocarcinoma
    Yeh, Chun-Nan
    Wang, Shang-Yu
    Chen, Yen-Yang
    Chen, Ming-Huang
    Chiang, Kun-Chun
    Cheng, Chi-Tung
    Tsai, Chun-Yi
    Wang, Chih-Chi
    Yeh, Ta-Sen
    Chen, Tse-Ching
    ANTICANCER RESEARCH, 2016, 36 (08) : 4249 - 4258
  • [4] The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT
    Manuel de la Torre-Aláez
    Carlota Jordán-Iborra
    Andrea Casadei-Gardini
    José Ignacio Bilbao
    Macarena Rodriguez-Fraile
    Lidia Sancho
    Delia D’Avola
    José Ignacio Herrero
    Mercedes Iñarrairaegui
    Bruno Sangro
    CardioVascular and Interventional Radiology, 2020, 43 : 1165 - 1172
  • [5] The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT
    de la Torre-Alaez, Manuel
    Jordan-Iborra, Carlota
    Casadei-Gardini, Andrea
    Bilbao, Jose Ignacio
    Rodriguez-Fraile, Macarena
    Sancho, Lidia
    D'Avola, Delia
    Herrero, Jose Ignacio
    Inarrairaegui, Mercedes
    Sangro, Bruno
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2020, 43 (08) : 1165 - 1172
  • [6] Pattern of progression determines post-progression survival in patients with hepatocellular carcinoma treated with Radioembolization
    Jordan, C.
    de la Torre, M.
    Gardini, A. C.
    Bilbao, J. I.
    Rodriguez-Fraile, M.
    Rodriguez, L. S.
    D'avola, D.
    Inarrairaegui, M.
    Herrero, J. I.
    Quiroga, J.
    Sangro, B.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S13 - S13
  • [7] Post-Progression Survival in Patients with Oligometastatic or Polymetastatic Pancreatic Adenocarcinoma
    Elamir, A.
    Sanford, N. N.
    Polanco, P.
    Porembka, M.
    Al Mutar, S.
    Kazmi, S.
    Beg, S. M.
    Timmerman, R. D.
    Zeh, H.
    Aguilera, T. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E295 - E295
  • [8] Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib
    Terashima, Takeshi
    Yamashita, Tatsuya
    Takata, Noboru
    Nakagawa, Hidetoshi
    Toyama, Tadashi
    Arai, Kuniaki
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    HEPATOLOGY RESEARCH, 2016, 46 (07) : 650 - 656
  • [9] Acquired gene alteration patterns and post-progression survival: PARADIGM study analysis
    Uetake, Hiroyuki
    Yamashita, Riu
    Shitara, Kohei
    Yoshino, Takayuki
    Watanabe, Jun
    Yasui, Hirofumi
    Ohori, Hisatsugu
    Shiozawa, Manabu
    Muro, Kei
    Yamazaki, Kentaro
    Oki, Eiji
    Sato, Takeo
    Naitoh, Takeshi
    Komatsu, Yoshito
    Kato, Takeshi
    Soeda, Junpei
    Yamamoto, Kouji
    Akagi, Kiwamu
    Ochiai, Atsushi
    Tsuchihara, Katsuya
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Suzuki, Eiichiro
    Kanogawa, Naoya
    Saito, Tomoko
    Motoyama, Tenyu
    Tawada, Akinobu
    Kanai, Fumihiko
    Yokosuka, Osamu
    INVESTIGATIONAL NEW DRUGS, 2016, 34 (02) : 255 - 260